Global Xerostomia Therapeutics Market by Offering (OTC, Prescription), Drug Type (Dentifrices, Salivary Stimulants, Salivary Substitutes), Distribution Channel - Forecast 2024-2030- Product Image

Sale

Global Xerostomia Therapeutics Market by Offering (OTC, Prescription), Drug Type (Dentifrices, Salivary Stimulants, Salivary Substitutes), Distribution Channel - Forecast 2024-2030

Report
185 Pages
March 2024
Region: Global
360iResearch™
ID: 5889726

UP TO €845EUR$875USD£723GBP OFF until Dec 31^st 2024

The Xerostomia Therapeutics Market size was estimated at USD 2.24 billion in 2023, USD 2.35 billion in 2024, and is expected to grow at a CAGR of 4.60% to reach USD 3.07 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Xerostomia Therapeutics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Xerostomia Therapeutics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Xerostomia Therapeutics Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Advanz Pharma Corp., Bausch Health Companies Inc., Bio Cosmetics Laboratories, S.L., Biodexa Pharmaceuticals PLC, CCMed Ltd., Chattem, Inc. by Sanofi S.A., Cipla Ltd., Colgate-Palmolive Company, Cyclacel Pharmaceuticals, Inc., Forward Science, Fresenius Kabi AG, Fresenius SE & Co. KGaA, GlaxoSmithKline PLC, Hikma Pharmaceuticals PLC, ICPA Health Products Ltd, Lupin Limited, Mission Pharmacal Company, Parnell Pharmaceuticals Inc., Perrigo Company plc, Pharmascience Inc., Quest Products Inc., Saliwell Ltd, Sun Pharmaceutical Industries Ltd., and Synedgen Inc.

Market Segmentation & Coverage

This research report categorizes the Xerostomia Therapeutics Market to forecast the revenues and analyze trends in each of the following sub-markets:

Offering
- OTC
- Prescription
Drug Type
- Dentifrices
- Salivary Stimulants
- Salivary Substitutes
Distribution Channel
- Hospital
- Pharmacies
  - Offline
  - Online

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

What is the market size and forecast of the Xerostomia Therapeutics Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Xerostomia Therapeutics Market?
What are the technology trends and regulatory frameworks in the Xerostomia Therapeutics Market?
What is the market share of the leading vendors in the Xerostomia Therapeutics Market?
Which modes and strategic moves are suitable for entering the Xerostomia Therapeutics Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Xerostomia Therapeutics Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing incidences of xerostomia in the aging population
5.1.1.2. Growing awareness about xerostomia-related products
5.1.1.3. Ongoing research and development for the development of efficient products for xerostomia
5.1.2. Restraints
5.1.2.1. High cost of medications and medical treatments associated with xerostomia therapies
5.1.3. Opportunities
5.1.3.1. Improvements in xerostomia drugs and treatments
5.1.3.2. Clinical trials to study the efficacy of xerostomia drugs
5.1.4. Challenges
5.1.4.1. Strict regulations pertaining to marketing and selling xerostomia-related products
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Xerostomia Therapeutics Market, by Offering

6.1. Introduction
6.2. OTC
6.3. Prescription

7. Xerostomia Therapeutics Market, by Drug Type

7.1. Introduction
7.2. Dentifrices
7.3. Salivary Stimulants
7.4. Salivary Substitutes

8. Xerostomia Therapeutics Market, by Distribution Channel

8.1. Introduction
8.2. Hospital
8.3. Pharmacies
8.4.1. Offline
8.4.2. Online

9. Americas Xerostomia Therapeutics Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Xerostomia Therapeutics Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Xerostomia Therapeutics Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

13.1. Key Company Profiles
13.1.1. 3M Company
13.1.2. Advanz Pharma Corp.
13.1.3. Bausch Health Companies Inc.
13.1.4. Bio Cosmetics Laboratories, S.L.
13.1.5. Biodexa Pharmaceuticals PLC
13.1.6. CCMed Ltd.
13.1.7. Chattem, Inc. by Sanofi S.A.
13.1.8. Cipla Ltd.
13.1.9. Colgate-Palmolive Company
13.1.10. Cyclacel Pharmaceuticals, Inc.
13.1.11. Forward Science
13.1.12. Fresenius Kabi AG
13.1.13. Fresenius SE & Co. KGaA
13.1.14. GlaxoSmithKline PLC
13.1.15. Hikma Pharmaceuticals PLC
13.1.16. ICPA Health Products Ltd
13.1.17. Lupin Limited
13.1.18. Mission Pharmacal Company
13.1.19. Parnell Pharmaceuticals Inc.
13.1.20. Perrigo Company plc
13.1.21. Pharmascience Inc.
13.1.22. Quest Products Inc.
13.1.23. Saliwell Ltd
13.1.24. Sun Pharmaceutical Industries Ltd.
13.1.25. Synedgen Inc.
13.2. Key Product Portfolio

14. Appendix

14.1. Discussion Guide
14.2. License & Pricing

List of Figures

FIGURE 1. XEROSTOMIA THERAPEUTICS MARKET RESEARCH PROCESS
FIGURE 2. XEROSTOMIA THERAPEUTICS MARKET SIZE, 2023 VS 2030
FIGURE 3. XEROSTOMIA THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. XEROSTOMIA THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. XEROSTOMIA THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. XEROSTOMIA THERAPEUTICS MARKET DYNAMICS
FIGURE 7. XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2023 VS 2030 (%)
FIGURE 8. XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
FIGURE 10. XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 12. XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS XEROSTOMIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS XEROSTOMIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES XEROSTOMIA THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES XEROSTOMIA THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC XEROSTOMIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC XEROSTOMIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. XEROSTOMIA THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. XEROSTOMIA THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. XEROSTOMIA THERAPEUTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. XEROSTOMIA THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 6. XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OTC, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PRESCRIPTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 9. XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DENTIFRICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. XEROSTOMIA THERAPEUTICS MARKET SIZE, BY SALIVARY STIMULANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. XEROSTOMIA THERAPEUTICS MARKET SIZE, BY SALIVARY SUBSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 13. XEROSTOMIA THERAPEUTICS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 16. XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. XEROSTOMIA THERAPEUTICS MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. AMERICAS XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS XEROSTOMIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 23. ARGENTINA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 24. ARGENTINA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 27. BRAZIL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 28. BRAZIL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 29. BRAZIL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 30. BRAZIL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 31. CANADA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 32. CANADA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 33. CANADA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 34. CANADA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 35. MEXICO XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 36. MEXICO XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 37. MEXICO XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 38. MEXICO XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES XEROSTOMIA THERAPEUTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 44. ASIA-PACIFIC XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 45. ASIA-PACIFIC XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 46. ASIA-PACIFIC XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 47. ASIA-PACIFIC XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 48. ASIA-PACIFIC XEROSTOMIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 49. AUSTRALIA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 50. AUSTRALIA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 51. AUSTRALIA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 52. AUSTRALIA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 53. CHINA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 54. CHINA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 55. CHINA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 56. CHINA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 57. INDIA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 58. INDIA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 59. INDIA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 60. INDIA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 61. INDONESIA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 62. INDONESIA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 63. INDONESIA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 64. INDONESIA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 65. JAPAN XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 66. JAPAN XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 67. JAPAN XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 68. JAPAN XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 69. MALAYSIA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 70. MALAYSIA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 71. MALAYSIA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 72. MALAYSIA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 73. PHILIPPINES XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 74. PHILIPPINES XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 75. PHILIPPINES XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 76. PHILIPPINES XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 77. SINGAPORE XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 78. SINGAPORE XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 79. SINGAPORE XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 80. SINGAPORE XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 81. SOUTH KOREA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 82. SOUTH KOREA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 83. SOUTH KOREA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 84. SOUTH KOREA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 85. TAIWAN XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 86. TAIWAN XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 87. TAIWAN XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 88. TAIWAN XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 89. THAILAND XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 90. THAILAND XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 91. THAILAND XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 92. THAILAND XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 93. VIETNAM XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 94. VIETNAM XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 95. VIETNAM XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 96. VIETNAM XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 102. DENMARK XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 103. DENMARK XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 104. DENMARK XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 105. DENMARK XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 106. EGYPT XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 107. EGYPT XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 108. EGYPT XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 109. EGYPT XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 110. FINLAND XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 111. FINLAND XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 112. FINLAND XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 113. FINLAND XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 114. FRANCE XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 115. FRANCE XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 116. FRANCE XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 117. FRANCE XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 118. GERMANY XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 119. GERMANY XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 120. GERMANY XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 121. GERMANY XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 122. ISRAEL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 123. ISRAEL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 124. ISRAEL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 125. ISRAEL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 126. ITALY XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 127. ITALY XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 128. ITALY XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 129. ITALY XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 130. NETHERLANDS XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 131. NETHERLANDS XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 132. NETHERLANDS XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 133. NETHERLANDS XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 134. NIGERIA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 135. NIGERIA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 136. NIGERIA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 137. NIGERIA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 138. NORWAY XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 139. NORWAY XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 140. NORWAY XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 141. NORWAY XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 142. POLAND XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 143. POLAND XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 144. POLAND XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 145. POLAND XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 146. QATAR XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 147. QATAR XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 148. QATAR XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 149. QATAR XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 150. RUSSIA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 151. RUSSIA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 152. RUSSIA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 153. RUSSIA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 154. SAUDI ARABIA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 155. SAUDI ARABIA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 156. SAUDI ARABIA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 158. SOUTH AFRICA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 159. SOUTH AFRICA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 160. SOUTH AFRICA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 161. SOUTH AFRICA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 162. SPAIN XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 163. SPAIN XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 164. SPAIN XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 165. SPAIN XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 166. SWEDEN XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 167. SWEDEN XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 168. SWEDEN XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 169. SWEDEN XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 170. SWITZERLAND XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 171. SWITZERLAND XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 172. SWITZERLAND XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 173. SWITZERLAND XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 174. TURKEY XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 175. TURKEY XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 176. TURKEY XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 177. TURKEY XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 178. UNITED ARAB EMIRATES XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 179. UNITED ARAB EMIRATES XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 180. UNITED ARAB EMIRATES XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 182. UNITED KINGDOM XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 184. UNITED KINGDOM XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 186. XEROSTOMIA THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 187. XEROSTOMIA THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 188. XEROSTOMIA THERAPEUTICS MARKET LICENSE & PRICING

Companies Mentioned

3M Company
Advanz Pharma Corp.
Bausch Health Companies Inc.
Bio Cosmetics Laboratories, S.L.
Biodexa Pharmaceuticals PLC
CCMed Ltd.
Chattem, Inc. by Sanofi S.A.
Cipla Ltd.
Colgate-Palmolive Company
Cyclacel Pharmaceuticals, Inc.
Forward Science
Fresenius Kabi AG
Fresenius SE & Co. KGaA
GlaxoSmithKline PLC
Hikma Pharmaceuticals PLC
ICPA Health Products Ltd
Lupin Limited
Mission Pharmacal Company
Parnell Pharmaceuticals Inc.
Perrigo Company plc
Pharmascience Inc.
Quest Products Inc.
Saliwell Ltd
Sun Pharmaceutical Industries Ltd.
Synedgen Inc.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	185
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 2.35 Billion
Forecasted Market Value ( USD ) by 2030	$ 3.07 Billion
Compound Annual Growth Rate	4.6%
Regions Covered	Global
No. of Companies Mentioned	25

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3259EUR$3,374USD£2,789GBP €3621EUR$3,749USD£3,099GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4128EUR$4,274USD£3,533GBP €4587EUR$4,749USD£3,925GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€4997EUR$5,174USD£4,276GBP €5552EUR$5,749USD£4,752GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5866EUR$6,074USD£5,020GBP €6518EUR$6,749USD£5,578GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7605EUR$7,874USD£6,508GBP €8450EUR$8,749USD£7,231GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects:

The report addresses key questions such as:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Xerostomia Therapeutics Market Size, Share & Trends Analysis Report By Type (OTC, Prescription), By Product (Salivary Stimulants, Salivary Substitutes, Dentifrices), By Region, And Segment Forecasts, 2023 - 2030

Xerostomia Therapeutics Market - Global Industry Size, Share, Trends Opportunity, and Forecast 2018-2028

Xerostomia (Dry Mouth Disease) Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

Xerostomia (Dry Mouth) Therapeutics - Global Strategic Business Report

Xerostomia (Dry Mouth) Therapeutics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type

About the Xerostomia Drug Market